A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome

a California Cancer Consortium Study

Mark H. Kirschbaum, Paul Frankel, Timothy W. Synold, Jasmine Zain, David Claxton, Joseph Tuscano, Edward M. Newman, David R. Gandara, Primo N. Lara

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)445-448
Number of pages4
JournalBritish Journal of Haematology
Volume180
Issue number3
DOIs
StatePublished - Feb 1 2018

Fingerprint

Recombinant Fusion Proteins
Vascular Endothelial Growth Factor Receptor
Myelodysplastic Syndromes
Vascular Endothelial Growth Factor A
Clinical Trials
Neoplasms
aflibercept

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Kirschbaum, Mark H. ; Frankel, Paul ; Synold, Timothy W. ; Zain, Jasmine ; Claxton, David ; Tuscano, Joseph ; Newman, Edward M. ; Gandara, David R. ; Lara, Primo N. / A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome : a California Cancer Consortium Study. In: British Journal of Haematology. 2018 ; Vol. 180, No. 3. pp. 445-448.
@article{dd67065238ae47a5ade227cfe16c81a6,
title = "A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study",
author = "Kirschbaum, {Mark H.} and Paul Frankel and Synold, {Timothy W.} and Jasmine Zain and David Claxton and Joseph Tuscano and Newman, {Edward M.} and Gandara, {David R.} and Lara, {Primo N.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1111/bjh.14333",
language = "English (US)",
volume = "180",
pages = "445--448",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",

}

A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome : a California Cancer Consortium Study. / Kirschbaum, Mark H.; Frankel, Paul; Synold, Timothy W.; Zain, Jasmine; Claxton, David; Tuscano, Joseph; Newman, Edward M.; Gandara, David R.; Lara, Primo N.

In: British Journal of Haematology, Vol. 180, No. 3, 01.02.2018, p. 445-448.

Research output: Contribution to journalLetter

TY - JOUR

T1 - A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome

T2 - a California Cancer Consortium Study

AU - Kirschbaum, Mark H.

AU - Frankel, Paul

AU - Synold, Timothy W.

AU - Zain, Jasmine

AU - Claxton, David

AU - Tuscano, Joseph

AU - Newman, Edward M.

AU - Gandara, David R.

AU - Lara, Primo N.

PY - 2018/2/1

Y1 - 2018/2/1

UR - http://www.scopus.com/inward/record.url?scp=84997611337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997611337&partnerID=8YFLogxK

U2 - 10.1111/bjh.14333

DO - 10.1111/bjh.14333

M3 - Letter

VL - 180

SP - 445

EP - 448

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -